{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T19:54:35Z","timestamp":1775591675515,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ymgme.2021.07.010","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T01:35:50Z","timestamp":1627263350000},"page":"96-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A review of treatment modalities in gyrate atrophy of the choroid and retina (GACR)"],"prefix":"10.1016","volume":"134","author":[{"given":"Berith M.","family":"Balfoort","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.N.","family":"Buijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneloor L.M.A.","family":"ten Asbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur A.B.","family":"Bergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camiel J.F.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise A.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riekelt H.","family":"Houtkooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet A.E.M.","family":"Wagenmakers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.A.","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans R.","family":"Waterham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrie","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara D.","family":"van Karnebeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion M.","family":"Brands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2021.07.010_bb0005","first-page":"140555","article-title":"Deficit of human ornithine aminotransferase in gyrate atrophy: molecular, cellular, and clinical aspects","volume":"2021","author":"Montioli","year":"1869","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0010","article-title":"Ornithine aminotransferase, an important Glutamate-Metabolizing enzyme at the crossroads of multiple metabolic pathways","volume":"6","author":"Ginguay","year":"2017","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1620\/tjem.205.335","article-title":"Vitamin B6-responsive ornithine aminotransferase deficiency with a novel mutation G237D","volume":"205","author":"Ohkubo","year":"2005","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0161-6420(00)00587-X","article-title":"Ophthalmologic heterogeneity in subjects with gyrate atrophy of choroid and retina harboring the L402P mutation of ornithine aminotransferase","volume":"108","author":"Peltola","year":"2001","journal-title":"Ophthalmology."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1073\/pnas.97.3.1224","article-title":"Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina","volume":"97","author":"Wang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0030","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1023\/A:1005602405349","article-title":"Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia","volume":"22","author":"Valtonen","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0035","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ophtha.2011.09.017","article-title":"Retinal structure, function, and molecular pathologic features in gyrate atrophy","volume":"119","author":"Sergouniotis","year":"2012","journal-title":"Ophthalmology."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0040","first-page":"113","article-title":"The proline\/Citrulline ratio as a biomarker for OAT deficiency in early infancy","volume":"4","author":"De Sain-van der Velden","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2008.12.010","article-title":"Secondary creatine deficiency in ornithine delta-aminotransferase deficiency","volume":"97","author":"Valayannopoulos","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0050","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1365-2362.1999.00569.x","article-title":"Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia","volume":"29","author":"Hein\u00e4nen","year":"1999","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0055","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jnnp.2006.101386","article-title":"Myopathy with tubular aggregates and gyrate atrophy of the choroid and retina due to hyperornithinaemia","volume":"78","author":"Fleury","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0060","series-title":"RESEARCH METHODS AND REPORTING The PRISMA 2020 statement : an updated guideline for reporting systematic reviews Systematic reviews and Meta-Analyses","author":"Page","year":"2021"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0065","first-page":"60","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"Evid. Based. Med."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF01811708","article-title":"A far advanced case of gyrate atrophy in a 12-year-old girl","volume":"14","author":"Bakker","year":"1991","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/13816810.2017.1301966","article-title":"Reversal of cystoid macular edema in gyrate atrophy patients","volume":"38","author":"Heller","year":"2017","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1752-1947-1-27","article-title":"Gyrate atrophy of the choroid and retina with hyper-ornithinemia responsive to vitamin B6: a case report","volume":"1","author":"Javadzadeh","year":"2007","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0085","first-page":"773","article-title":"Gyrate atrophy of the choroid and retina: long-term reduction of ornithine slows retinal degeneration","author":"Kaiser-Kupfer","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0090","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/archopht.122.7.982","article-title":"Use of an arginine-restricted diet to slow progression of visual loss in patients with gyrate atrophy","volume":"122","author":"Kaiser-Kupfer","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0095","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.7444439","article-title":"Gyrate atrophy of the choroid and retina: Improved visual function following reduction of plasma ornithine by diet","volume":"210","author":"Kaiser-Kupfer","year":"1980","journal-title":"Science (80-. )"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-014-9426-1","article-title":"OAT mutations and clinical features in two Japanese brothers with gyrate atrophy of the choroid and retina","volume":"128","author":"Katagiri","year":"2014","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0105","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3341\/kjo.2013.27.5.388","article-title":"Gyrate atrophy of the choroid and retina diagnosed by ornithine-\u03b4-aminotransferase gene analysis: a case report","volume":"27","author":"Kim","year":"2013","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/opge.20.4.219.2271","article-title":"Genotype-phenotype correlation of a pyridoxine-responsive form of gyrate atrophy","volume":"20","author":"Mashima","year":"1999","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0115","first-page":"226","article-title":"Treatment of gyrate atrophy of the choroid and retina with low arginine diet","volume":"78","author":"McInnes","year":"1980","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0120","first-page":"616","article-title":"Pyridoxine-responsive gyrate atrophy of the choroid and retina: clinical and biochemical correlates of the mutation A226V","volume":"56","author":"Michaud","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0125","first-page":"1","article-title":"Resolution of cystoid macular edema following arginine-restricted diet and vitamin B6 supplementation in a case of gyrate atrophy","volume":"1","author":"Casalino","year":"2011","journal-title":"J. AAPOS."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0035-1555921","article-title":"Gyrate atrophy in 2 siblings - ophthalmological findings and a new mutation","volume":"227","author":"Michel","year":"2015","journal-title":"Klin. Padiatr."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1005638004530","article-title":"Oral lysine feeding in gyrate atrophy with hyperornithinaemia - a pilot study","volume":"23","author":"Peltola","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jaapos.2010.07.011","article-title":"Occipital porencephaly in a child with gyrate atrophy of the choroid and retina","volume":"14","author":"Rigante","year":"2010","journal-title":"J. AAPOS."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/B:BOLI.0000028779.29966.05","article-title":"Low-protein diet and progression of retinal degeneration in gyrate atrophy of the choroid and retina: a twenty-six-year follow-up","volume":"27","author":"Santinelli","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.eye.6702009","article-title":"Gyrate atrophy with bilateral full thickness macular hole","volume":"20","author":"Sharma","year":"2006","journal-title":"Eye."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0009-8981(81)90278-3","article-title":"Reduction of hyperornithinemia with a low protein, low arginine diet and pyridoxine in patients with a deficiency of ornithine-ketoacid transaminase (OKT) activity and gyrate atrophy of the choroid and retina","volume":"113","author":"Shih","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0160","first-page":"2","article-title":"First reported cases of gyrate atrophy of the choroid from Nepal","author":"Shrestha","year":"2010","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0165","first-page":"1981","article-title":"Treatment of hyperornithinaemia and gyrate atrophy of choroid and retina with low-protein diet","author":"Stoppoloni","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0170","first-page":"2010","article-title":"Gyrate atrophy of the choroid and retina with hyperornithinemia, cystinuria and lysinuria responsive to vitamin B6","author":"Tanzer","year":"2011","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1172\/JCI109680","article-title":"Gyrate atrophy of the choroid and retina. Amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet","volume":"65","author":"Valle","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5935\/0004-2749.20200028","article-title":"Regression of macular edema with topical brinzolamide and nepafenac alone and identification of a novel gyrate atrophy mutation","volume":"83","author":"\u00c7avdarli","year":"2020","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0185","first-page":"396","article-title":"Metabolic follow-up of a Croatian patient with gyrate atrophy and a new mutation in the OAT gene: a case report","volume":"26","author":"Zekusic","year":"2014","journal-title":"Biochem Med."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-018-0755-9","article-title":"Multimodal imaging of foveoschisis and macular pseudohole associated with gyrate atrophy: a family report","volume":"18","author":"Zhioua Braham","year":"2018","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0195","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/000456329903600419","article-title":"Hyperornithinaemia associated with gyrate atrophy of the choroid and retina: two cases from India","volume":"36","author":"Christopher","year":"1999","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0200","first-page":"139","article-title":"Multimodal characterization of a novel mutation causing vitamin B6-responsive gyrate atrophy","volume":"176","author":"Cui","year":"2017","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0205","first-page":"1","article-title":"Arginine-restricted therapy resistant bilateral macular edema associated with gyrate atrophy","volume":"2015","author":"Doguizi","year":"2015","journal-title":"Case Rep. Ophthalmol. Med."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0210","series-title":"Sustained oral lysine supplementation in ornithine delta-aminotransferase deficiency","first-page":"312","volume":"24","author":"Elpeleg","year":"2001"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00006982-198909020-00014","article-title":"Epiretinal membranes and cystoid macular edema in gyrate atrophy of the choroid and retina","author":"Feldman","year":"1989","journal-title":"Retina"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bjo.69.4.283","article-title":"Clinical trials of vitamin B6 and proline supplementation for gyrate atrophy of the choroid and retina","volume":"69","author":"Hayasaka","year":"1985","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0225","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/humu.22233","article-title":"Functional analysis of missense mutations of OAT, causing gyrate atrophy of choroid and retina","volume":"34","author":"Doimo","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0230","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1074\/jbc.M117.788422","article-title":"Human retinal pigment epithelial cells prefer proline as a nutrient and transport metabolic intermediates to the retinal side","volume":"292","author":"Chao","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0235","doi-asserted-by":"crossref","first-page":"100846","DOI":"10.1016\/j.preteyeres.2020.100846","article-title":"The cell biology of the retinal pigment epithelium","volume":"78","author":"Lakkaraju","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0240","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1017\/S0007114511003291","article-title":"Retinal risks of high-dose ornithine supplements: a review","volume":"106","author":"Hayasaka","year":"2011","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ophtha.2009.03.039","article-title":"Retinal degeneration","volume":"116","author":"Morini","year":"2009","journal-title":"Ophthalmology."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0250","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.120.2.146","article-title":"Gyrate atrophy of the choroid and retina: further experience with long-term reduction of ornithine levels in children","volume":"120","author":"Kaiser-Kupfer","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0255","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ejcn.2017.102","article-title":"Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases","volume":"72","author":"Mlcoch","year":"2018","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0260","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clinbiochem.2013.11.021","article-title":"The chaperone role of the pyridoxal 5\u2032-phosphate and its implications for rare diseases involving B6-dependent enzymes","volume":"47","author":"Cellini","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2019.04.004","article-title":"International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria","volume":"127","author":"Muntau","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0270","series-title":"Online Metab","article-title":"The Hyperornithinemias","author":"Valle","year":"2019"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0275","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.bbadis.2018.08.032","article-title":"Molecular and cellular basis of ornithine \u03b4-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina","volume":"1864","author":"Montioli","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0280","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.85.11.3777","article-title":"Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and -nonresponsive forms of gyrate atrophy","volume":"85","author":"Ramesh","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0285","series-title":"Vitamin B6 Safety Issues","author":"Bendich","year":"1986"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0290","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.59.5.735","article-title":"Peripheral nervous system in gyrate atrophy of the choroid and retina with hyperornithinemia","volume":"59","author":"Peltola","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.metabol.2006.09.011","article-title":"Long-term oral lysine supplementation in lysinuric protein intolerance","volume":"56","author":"Tanner","year":"2007","journal-title":"Metabolism."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0300","doi-asserted-by":"crossref","first-page":"2561S","DOI":"10.1093\/jn\/nxaa218","article-title":"Comprehensive safety assessment of l-lysine supplementation from clinical studies: a systematic review","volume":"150","author":"Hayamizu","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0305","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00726-010-0715-z","article-title":"Proline and hydroxyproline metabolism: implications for animal and human nutrition","volume":"40","author":"Wu","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.ymgme.2021.07.010_bb0310","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/13816810.2018.1536220","article-title":"Bevacizumab for the treatment of intraretinal cystic spaces in a patient with gyrate atrophy of the choroid and retina","volume":"39","author":"Elnahry","year":"2018","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0315","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s10792-017-0579-2","article-title":"Bilateral choroidal neovascularization associated with gyrate atrophy managed with intravitreal bevacizumab","volume":"38","author":"Inanc","year":"2018","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0320","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.5301\/ejo.5001010","article-title":"Carbonic anhydrase inhibitor with topical NSAID therapy to manage cystoid macular edema in a case of gyrate atrophy","volume":"27","author":"Piozzi","year":"2017","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0325","doi-asserted-by":"crossref","first-page":"246","DOI":"10.22336\/rjo.2018.37","article-title":"Cystoid macular edema secondary to gyrate atrophy in a child treated with sub-tenon injection of triamcinolone acetonide","volume":"62","author":"Alparslan","year":"2018","journal-title":"Rom. J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0330","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1590\/S0004-27492007000500024","article-title":"Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report","volume":"70","author":"Vasconcelos-Santos","year":"2007","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0335","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.survophthal.2017.09.009","article-title":"Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review","volume":"63","author":"Bakthavatchalam","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0340","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biochi.2015.10.022","article-title":"Creatine biosynthesis and transport in health and disease","volume":"119","author":"Joncquel-Chevalier Curt","year":"2015","journal-title":"Biochimie."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0345","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1055\/s-0034-1386772","article-title":"Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders","volume":"34","author":"Stockler-Ipsiroglu","year":"2014","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0350","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1212\/WNL.53.2.303","article-title":"Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia","volume":"53","author":"N\u00e4nt\u00f6-Salonen","year":"1999","journal-title":"Neurology."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0355","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10633-012-9335-0","article-title":"Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation","volume":"125","author":"Renner","year":"2012","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0360","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1136\/bcr-2016-217556","article-title":"Unique case of gyrate atrophy with a well-preserved electroretinogram (ERG)","volume":"2018","author":"Jasani","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.9.7.2","article-title":"Advancing clinical trials for inherited retinal diseases: Recommendations from the second monaciano symposium","volume":"9","author":"Thompson","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0370","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1167\/iovs.17-22339","article-title":"Report from the NEI\/FDA endpoints workshop on age- related macular degeneration and inherited retinal diseases","volume":"58","author":"Csaky","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0375","first-page":"1","article-title":"Defining inclusion criteria and endpoints for clinical trials: a prospective cross-sectional study in CRB1-associated retinal dystrophies","author":"Talib","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0380","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/APO.0000000000000290","article-title":"Retinal dystrophies and the road to treatment: clinical requirements and considerations","volume":"9","author":"Talib","year":"2020","journal-title":"Asia-Pacific J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.010_bb0385","first-page":"185","article-title":"Establishing patient registries for rare diseases: rationale and challenges","volume":"34","author":"Boulanger","year":"2020","journal-title":"Pharmaceut. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:53:03Z","timestamp":1761090783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":77,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1096719221007629"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.07.010","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of treatment modalities in gyrate atrophy of the choroid and retina (GACR)","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}